The Center for Translational Molecular Medicine (CTMM) reported it will fund eight R&D projects on new techniques for the diagnosis and treatment of major diseases with almost €250 million, or $319 million. The Dutch government will contribute half the funding, with the rest coming from the industry and academia.
The funding will be allocated to 13 university medical centers and research institutes, 29 SMEs (small- and medium-sized enterprises), and 15 industrial organizations.
The newly approved projects include those that target cancer as well as cardiovascular, neurodegenerative, and infectious diseases, says the center. New technology platforms such as medical imaging techniques that can be applied across a broad spectrum of these diseases will also be developed.
The CTMM says it will also continue to invest in centralized infrastructures for company projects to address the demand for advanced genomics, proteomics, metabolomics, and bioinformatics.